1. Signaling Pathways
  2. Cell Cycle/DNA Damage
  3. CDK
  4. Pho85 Isoform

Pho85

Pho85 is a multifunctional cyclin-dependent kinase (CDK) in Saccharomyces cerevisiae that integrates nutrient sensing, metabolic regulation, and cell-cycle control through association with multiple cyclin partners (Pcls)[1]. Unlike the essential cell-cycle CDK Cdc28, Pho85 operates through at least ten cyclins that direct substrate specificity across distinct biological processes, including phosphate homeostasis, glycogen metabolism, polarized growth, and G1/S transition regulation[1][2]. Mechanistically, the Pho80-Pho85 complex phosphorylates the transcription factor Pho4 under phosphate-replete conditions, thereby repressing PHO pathway gene expression and maintaining phosphate homeostasis[3]. Pho85-dependent signaling also interfaces with broader nutrient-responsive networks; Pho85 promotes TORC1-Sch9 signaling by regulating Sch9 recruitment and priming phosphorylation, linking phosphate availability to cellular growth control[4]. In experimental models, Pho85 has become an important system for studying noncanonical CDK functions because its regulatory architecture differs from classical cell-cycle CDKs and allows environmental signals to be coupled directly to transcriptional and metabolic responses[2]. Compared with related CDKs, Pho85 exhibits unusually broad functional diversity through cyclin-dependent substrate targeting, making cyclin composition a major determinant of pathway specificity[1][5]. For research applications, chemical inhibition of Pho85 has been used to dissect stress-response pathways and nutrient-regulated transcriptional programs, providing a useful experimental framework for investigating CDK-mediated environmental adaptation[6].

Pho85 Related Products (1):

Cat. No. Product Name Effect Purity
  • HY-153556
    GW297361
    Inhibitor 98.13%
    GW297361 is an oxindole CDK inhibitor that elicits a Pho85-selective response in cells. GW297361 inhibits yeast Cdk1 and Pho85 with IC50s of 20 nM and 400 nM in vitro, respectively.